Utah Medical Products (UTMD) Current Leases (2022 - 2023)

Utah Medical Products' (UTMD) quarterly Current Leases came in at $47000.0 in Q4 2023, down 12.96% year-on-year from $54000.0 in Q4 2022, and down 12.96% quarter-over-quarter from $54000.0 in Q4 2022.

Utah Medical Products (UTMD) Current Leases (2022 - 2023) Analysis & Trends

Utah Medical Products' Current Leases history runs 2 years deep, the most recent figure standing at $47000.0 for Q4 2023.

  • On a quarterly basis, Current Leases fell 12.96% year-over-year to $47000.0 in Q4 2023; TTM through Dec 2023 was $47000.0, a 12.96% decrease from a year earlier, with the FY2023 full-year figure at $47000.0, down 12.96% from the prior year.
  • Current Leases fell to $47000.0 in Q4 2023 per UTMD's latest filing, from $54000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $54000.0 in Q4 2022 and bottomed at $47000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 29.23 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 20.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Utah Medical Products 204.41 Mn 117.01 Mn 5.28 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 47,000.00
Dec 31, 2022 54,000.00